Lateral Flow Assays Market is projected to reach a valuation of US$ 6.9 billion at a CAGR of 4.7% by

The Lateral Flow Assays Market is anticipated to be valued at US$ 4.3 billion in 2023, growing to US$ 6.9 billion by 2033. During the forecast period, lateral flow assay sales are expected to expand at a CAGR of 4.7%.The market profited from the COVID-19 pandemic. The use of lateral flow test kits, which are smaller...

Related Keywords

New York ,United States ,Delaware ,United Kingdom ,China , ,Scanwell Health Mobile App ,Pharmaceuticals Biotechnology Companies ,Market Insights Inc ,Neumodx Molecular Inc ,Roche Ltd ,Thermo Fisher Scientific Inc ,Quidel Corporation ,Drug Development Quality Testing ,Abbott Laboratories ,Greater New York Chamber ,Danaher Corporation ,Lateral Flow Assays Market ,Players Include ,Scanwell Health Mobile ,United States Track ,Neumodx Molecular ,Segments Covered ,Sample Type ,End User ,Future Market Insights ,Market Insights ,Sales Channel ,End Use ,Sales Enquiries ,All Reports ,